Accelerate drug discovery with AI-AAM: Using AI to discover drugs and improve existing compounds

""
Watch On Demand

Traditional drug discovery is time-consuming, and expensive, and numerous industry studies are showing a year-on-year decrease in return on investment from R&D efforts across the board. Join FUJIFILM Wako in this webinar to learn more about how AI-AAM (AI-Amino-Acid Mapping), its new proprietary scaffold-hopping method based on AI and chemical simulation techniques, can be used to address this challenge, accelerating the identification of hit compounds and improvements in compound structure for small molecules and peptides.

FUJIFILM Wako has commercialised the AI-AAM method as the ‘drug2drugs CRO service’, now available in the US and European markets. The service offers clients the ability to discover novel drugs from the structure of a single active compound and improve upon the thermal stability, synthesizability, toxicity, and other aspects of the structure of a drug, without the need for the protein structure and primary sequence of the target protein.

Related Articles